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ABSTRACT
This study investigated the genetic structure of the cap region of an isolate of Haemophilus influenzae
serotype a (Hia) from the cerebrospinal fluid (CSF) of a child with meningitis. In addition, the genetic
structure of the cap region of a non-serotypeable H. influenzae isolate, obtained simultaneously from the
blood of the same patient, was determined. According to restriction fragment length polymorphism
analysis, the CSF and blood isolates were identical, with the exception of a single band shift of c. 35 kb.
PCR analyses suggested that the CSF isolate possessed the IS1016–bexA gene and cap region II, whereas
the blood isolate only had the IS1016 element. Furthermore, Southern analysis of DNA from both
isolates showed that the CSF isolate carried the cap gene(s), while the blood isolate did not. Using a novel
quantitative real-time PCR approach for determining the cap copy number, it was demonstrated that the
CSF isolate had two intact tandem repeats of the cap gene containing three copies of IS1016, whereas the
blood isolate had only one copy of IS1016. This study provided evidence that H. influenzae serotypes
other than serotype b can cause serious disease, and that the virulence of these non-serotype b strains
relates primarily to the cap gene copy number and the structure of the cap locus. Therefore, the
quantitative real-time PCR assay described in this study should be useful for the rapid and definitive
identification of strains of H. influenzae type a that represent a risk for serious disease.
Keywords cap gene, Haemophilus influenzae serotype a, meningitis, PCR, quantitative real-time PCR, restriction
fragment length polymorphism analysis
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INTRODUCTION
Haemophilus influenzae is an important bacterial
pathogen in children, causing a variety of respir-
atory infections and life-threatening diseases,
such as meningitis, epiglottitis and septic arthritis.
With the dramatic decline of H. influenzae type b
(Hib) invasive disease following widespread use
of the Hib vaccine, systemic infections caused by
non-type b encapsulated strains have increased in
frequency [1–4]. The H. influenzae capsule, and the
genes involved in capsule expression, are major
virulence determinants [5,6]. The capsule (cap)
locus is c. 18 kb in size, and can be divided into
three functionally distinct regions, designated I, II
and III [6]. This organisation is common to all six
capsular types (i.e., serotypes a–f). Region II is
serotype-specific, and is sandwiched between
regions I and III, which are common to all
capsular serotypes [7]. Enzymes encoded by
region II synthesise the type-specific disaccharide
[8,9].
Most invasive Hib isolates possess a duplica-
tion of the 18-kb cap locus, with the two copies
separated and bounded by an insertion-like
sequence designated IS1016 [10]. However, the
two cap loci are not identical, since one has a
deletion of c. 1.2 kb of a portion of bexA and
IS1016 [11]. This partially duplicated arrangement
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is likely to allow further amplification of the
capsule gene and an increase in capsular poly-
saccharide production, which enhances the viru-
lence of Hib strains [12]. However, there is
evidence that the genetic region encoding the
Hib capsule is unstable, and Hib strains lose
capsule expression spontaneously at frequencies
of 0.1–0.5% [10]. For example, deletion of one
copy of the 18-kb repeat, through a rec-dependent
recombination event, results in an inability to
synthesise the Hib capsule [10,11]. In fact, non-
encapsulated Hib mutants (b– strains) have been
reported previously [13–17]. However, there have
been no previous reports of capsule-deficient




The bacteria used in this study were isolates from routine
cultures performed on specimens from a child with meningitis.
An H. influenzae serotype a (Hia) isolate was obtained from
cerebrospinal fluid (CSF), and an untypeable H. influenzae
strain was isolated from blood. Suspensions of both isolates
were stored at ) 80C in brain–heart infusion broth supple-
mented with glycerol 20% v ⁄v; subcultures were minimised to
avoid spontaneous loss of capsule production. The isolates
were identified by conventional methods, serotyped by slide
agglutination using H. influenzae serotype-specific rabbit anti-
sera (Becton Dickinson Bioscience, Cockeysville, MD, USA),
and biotyped on the basis of indole production and urease and
ornithine decarboxylase activity [18]. Production of b-lacta-
mase was determined using cefinase disks (Becton Dickinson
Bioscience).
Isolation of chromosomal DNA
Chromosomal DNAwas prepared by suspending c. 30 colonies
from a chocolate agar (Becton Dickinson Bioscience) plate in
300 lL of sterile distilled water, boiling for 10 min, and then
centrifuging at 2700 g for 10 min. The DNA was purified
further using a QIAamp DNA Mini Kit (Qiagen, Crawley, UK)
and stored at ) 20C.
Restriction fragment length polymorphism (RFLP) analysis
Bacteria were subcultured on chocolate agar at 35C in CO2 5%
v ⁄v for 18–24 h. The bacteria were suspended at
5 · 108 cells ⁄mL in wash buffer (10 mM Tris, 1 M NaCl,
pH 7.6), harvested by centrifugation at 2700 g for 15 min at
4C, and resuspended in 500 lL of wash buffer. The suspen-
sion was mixed with an equal volume of molten agarose
(SeaKem GTG; BMA, Rockland, ME, USA) 1.6% w ⁄v and
dispensed quickly into the wells of a plug mould. The plugs
were incubated with lysozyme (1 mg ⁄mL) for 6 h at 37C, and
then with proteinase K (500 lg ⁄mL) at 50C overnight, and
were then washed five times with TE buffer (10 mM Tris-HCl,
1 mM EDTA, pH 8.0). The embedded DNA was digested
overnight with 20 U of SmaI, ApaI, SacII or NaeI (New England
BioLabs, Beverly, MA, USA). Large restriction fragment
patterns were analysed by pulsed-field gel electrophoresis
(PFGE) in agarose 1% w ⁄v gels, with run conditions of 200 V
for 22 h at 14C and pulse times of 5–50 s (for SmaI) or 2–25 s
(for ApaI, SacII or NaeI), ramped linearly using the CHEF-DR II
system (Bio-Rad Laboratories, Hercules, CA, USA). These
conditions were chosen to optimise the separation of frag-
ments in the ranges 25–700 kb or 25–500 kb, respectively. A
lambda DNA ladder (New England BioLabs) was used as a
molecular size marker. The gels were stained with ethidium
bromide and photographed with UV light. The RFLP patterns
were compared by visual inspection and interpreted using the
criteria proposed by Tenover et al. [19].
In some instances, DNA bands generated by an initial RFLP
analysis were digested with a second enzyme. The bands,
usually in duplicate, were cut from the agarose and washed
four times in TE buffer, and then once in restriction enzyme
buffer, for 1 h at room temperature with gentle mixing. The
fragments were digested with 60 U of KpnI (New England
BioLabs) overnight at 37C. PFGE was performed for 13 h at
14C and 200 V with a ramped pulse time of 1–3 s.
PCR analysis and DNA sequencing
Hia cap genes were identified using PCR primers that
amplified Hia-specific DNA. Additional primers were
designed for amplifying the cap region II (Hia-specific DNA)
and for identifying IS1016 (Table 1). Two primers described
previously (HI-1 and HI-2) [20] were used to distinguish
typeable (encapsulated) from untypeable (non-encapsulated)
strains of H. influenzae. Published sequence information for
H. influenzae strain Rd KW20 was used to design PCR primers
for the DNA surrounding the IS1016 locus [21]. Rd KW20 is a
capsule-deficient strain derived by in-vitro passage of an
H. influenzae type d strain [22], which was discovered during
the analysis of sequencing information to also possess the
IS1016 element. IS1016–bexA deletions were identified by PCR,
as described previously [23].
PCRs were performed by activation of HotStarTaq DNA
polymerase (Qiagen) at 95C for 15 min, followed by 35 cycles
of 94C for 1 min, 50 or 53C for 1 min and 72C for 1 min,
with a final incubation at 72C for 10 min. PCR products were
analysed by polyacrylamide gel electrophoresis (Invitrogen,








A HiaCAPII-1 GCGTAATGAGCGTATCGATGTAAGC 1076 This study
HiaCAPII-2 TTGGCGAATTTTCACAAACCTCTAT This study
B HI-1 TGTCCATGTCTTCAAAATGATG 343 [14]
HI-2 TGATGAGGTGATTGCAGTAGG [14]
C IS1016-1 ATTAGCAAGTATGCTAGTCTATA 497 [14]
IS1016-3 ACCGCAAATAGTTCGGAATG This study
D IS-Left-1 CACTTTGCTGTGCTTGAGCTA 182 This study
IS-Left-2 ACCCGTGAACCTGAAACAGT This study
E IS-Right-1 ACAGGCCTCAAGACAGGAAC 153 This study
IS-Right-2 TTACGGGAGTAGCTGGTGGT This study
F IS-Left-1 CACTTTGCTGTGCTTGAGCTA 433 This study
IS1016-4 GAGTAAATCAGCCGCTGCTC This study
G IS1016-5 CTTGATGCGAGCAAATTTCA 514 This study
IS-Right-2 TTACGGGAGTAGCTGGTGGT This study
H IS-Left-1 CACTTTGCTGTGCTTGAGCTA 1262 This study
IS-Right-2 TTACGGGAGTAGCTGGTGGT This study
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Carlsbad, CA, USA). Gels were stained with ethidium bromide
and photographed with Polaroid type 57 film. For DNA
sequencing, PCR products were purified using a Qiaquick gel
extraction kit (Qiagen) and sequenced by a commercial
laboratory (Laragen, Los Angeles, CA, USA).
Southern hybridisation
The chromosomal location of cap genes in SmaI- or ApaI-
digested DNA fragments was analysed by Southern blot using
a probe specific for the cap locus. The probe was a biotin-
labelled (BrightStar psoralen–biotin non-isotopic labelling kit;
Ambion, Austin, TX, USA) 1.1-kb PCR product (primer set A;
Table 1). Hybridisation was performed at 42C in ULTRAhyb
hybridisation buffer (Ambion). Following one wash in 2 · SSC
(20 · SSC = 3 M NaCl, 0.3 M Na3 citrate) plus sodium dodecyl
sulphate 0.5% w ⁄v, and two washes in 0.1 · SSC plus sodium
dodecyl sulphate 0.5% w ⁄v at 50C, the bound probe was
detected using the BrightStar BioDetect non-isotopic detection
kit (Ambion) and exposure to Kodak BioMax Light film.
Quantitative real-time PCR
Real-time PCR was used to quantify the number of copies of
the cap locus per genome. To achieve this, primer pairs
(Table 2) were designed to target: (1) the rpoB gene (a single-
copy gene; primer set I); (2) an Hia-specific locus (primer set
K); and (3) the IS1016 region (primer set M). H. influenzae rpoB-
specific regions of the 16S rRNA gene were identified from
sequence databases. For the Hia-specific DNA, the primers
were altered to generate smaller amplification products in
order to improve the efficiency of the PCR assay with SYBR
Green. The real-time PCRs were performed with an iCycler iQ
system (Bio-Rad) using SYBR Green fluorescence for detection
and quantification of amplified products. The optimised
reaction mixtures contained 2 · QuantiTect SYBR Green
(Qiagen), 2.5 mM MgCl2 (final concentration), 0.2 mM each
primer and 1 lL of the extracted DNA. All reactions were run
in a 96-well PCR plate (Bio-Rad) in a total volume of
25 lL ⁄well. The PCR conditions comprised an initial Taq
activation step of 95C for 15 min, and 40 cycles of 30 s at 94C,
30 s at 53C, and 30 s at 72C. Fluorescence was monitored
during each cycle at the end of the annealing phase.
To normalise the amplification ⁄detection efficiencies of the
three PCRs, assay-specific quantitative standards (c. 1 kb)
were generated by PCR using primer sets J, L and N
(Table 2). These standards spanned the target sites of the
rpoB, IS1016 and cap locus PCR products described above.
Each standard was amplified from the CSF isolate, and then
extracted and purified using Qiaquick gel extraction kits
(Qiagen). The concentration of the purified DNA standards
was determined using a DNA 7500 Laboratory Chip and 2100
Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA).
Solutions containing 1 nmol ⁄L of each of the purified DNA
preparations were used as quantitative standards. A series of
five dilutions corresponding to 105)10 fmol ⁄L were prepared
and run in duplicate as external standards in parallel with
the test DNA. To generate a standard curve, the threshold
cycle (CT) of the standard dilutions was plotted against the
DNA concentration. The linear correlations between the CT
values and DNA concentrations were identical for all three
PCR assays (R2 = 1.0), with slopes of ) 3.695, ) 3.889 and
) 4.172 for the rpoB, cap and IS1016 PCR targets, respectively.
The specificities of the assays were confirmed by the sizes of
the PCR products and the melting curve analyses. The
number of copies of cap or IS1016 was calculated from the




Routine bacterial cultures of the CSF and blood
from a patient with meningitis yielded pure
cultures of small Gram-negative bacilli with
distinct colonial morphologies on chocolate agar.
Table 2. Oligonucleotide PCR prim-












I rpoB-1 R TTGGTGGTCAGCGTTTCGGTGAGA 68.1 U32733
(7265-7242)
172
rpoB-2 F GATTCCGGTGTGCCTGGCTCCATA 68.9 U32733
(7094–7117)
J rpoB-3 R AAGGTGGCGACATCTTAGTAGGTAA 64.6 U32733
(8426–8402)
1368
rpoB-4 F CAAGTGAGCGGATTTCTTTCATAAT 65.0 U32733
(7059–7082)
K HiaCAP-1 F CCTGGGGCAAAATTAATACATCG 66.7 Z37517
(3359–3382)
211
HiaCAP-2 R AAGGCTTTTATATCACGTTGCTGTG 65.8 Z37517
(3602–3577)
L HiaCAPII-1 F GCGTAATGAGCGTATCGATGTAAGC 68.1 Z37517
(2885–2909)
1076
HiaCAPII-2 R TTGGCGAATTTTCACAAACCTCTAT 67.0 Z37517
(3990–3966)
M IS1016-5 F CTTGATGCGAGCAAATTTCA 63.8 X58174
(482–501)
239
IS1016-6 R CCCTAAATACCACTCCATTTTCG 64.1 X58174
(720–698)
N IS1016-L1 F CACTTTGCTGTGCTTGAGCTA 63.2 U32782
(8525–8505)
1262
IS1016-R2 R TTACGGGAGTAGCTGGTGGT 63.4 U32782
(7264–7283)
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The isolate from CSF (designated KO100) had a
mucoid colonial morphology typical of an encap-
sulated strain of H. influenzae, and was serotyped
as type a. In contrast, the isolate from blood
(designated KO101) had a colonial morphology
that was convex and non-mucoid, and did not
react with any of the serotyping reagents (sero-
types a–f). Both isolates belonged to biotype II,
and were positive for indole and urease, but
negative for ornithine and b-lactamase.
Strain identity
RFLP analyses of the chromosomal DNA from
KO100 and KO101, using four different restriction
enzymes, indicated that the two isolates were the
same strain (Fig. 1a)1d). However, while the
restriction patterns for each isolate had the same
total number of bands, three of the restriction
analyses (with SmaI, ApaI and SacII) identified a
single band shift of c. 35 kb (for example, in the
SmaI PFGE analysis, there was a 530-kb band in
the KO100 pattern, compared with a 495-kb band
in the KO101 pattern).
To investigate the nature of this difference, the
two discrepant SmaI restriction fragments were
purified and digested with KpnI. The resulting
KpnI restriction patterns are depicted in Fig. 1e,
and show a single band difference between the
two isolates (i.e., a 45-kb band in KO100, com-
pared with a 10-kb band in KO101). The differ-
ences in the combined SmaI ⁄KpnI restriction
patterns can be explained most simply by the
deletion of a c. 35-kb DNA fragment from the
genome of KO101.
The finding that the two isolates were probably
the same strain suggested that the untypeable
nature of KO101 resulted from lack of expression
of the type a capsule. This was investigated using
Southern analysis to screen for the cap locus in the
two isolates (Fig. 2). This analysis substantiated
the hypothesis that KO101 lacked the cap region
II, and that this loss was linked to the 35-kb band
shift seen in the PFGE patterns for this organism.
PCR analyses of the cap locus with eight primer
pairs suggested that KO100 possessed IS1016, the
bexA gene and the cap region II, whereas
KO101 had only IS1016 (Fig. 3). The PCR prod-
ucts produced using primer sets C (497 bp),
F (433 bp) and G (514 bp) from both KO100 and
KO101, and H (1262 bp) from KO101, were




































CSF BloodM CSF BloodM CSF BloodM CSF BloodM
ApaI SacII SmaI/KpnI
Fig. 1. Pulsed-field gel fingerprints of Haemophilus influenzae isolates digested with (a) SmaI, (b) ApaI, (c) SacII, or (d) NaeI.
(e) The c. 530-kb SmaI fragment from the cerebrospinal fluid isolate (KO100), and the c. 495-kb SmaI fragment from the
blood isolate (KO101) following digestion with KpnI. M, lambda ladder molecular size marker. Arrows indicate a single
band shift difference between KO100 and KO101 of c. 35 kb.
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the IS1016 element, including all of IS1016 itself,
were identical in both KO100 and KO101 (data
not shown). It was concluded from these data that
the non-encapsulated, untypeable isolate from
blood (KO101) is a capsule-deficient variant of the
Hia isolate (KO100) from CSF.
Number of cap genes
Three quantitative real-time PCR assays (Table 2)
were used to determine the number of cap genes
per genome in KO100: (1) the single-copy rpoB
gene; (2) the IS1016 element; and (3) the cap
gene(s). The ratios of cap and IS1016 PCR prod-
ucts to rpoB product indicated that there were two
copies of the cap sequence and three copies of the
IS1016 sequence (Table 3). These results are con-
sistent with the RFLP and PCR-mapping results
described above, and also indicate that KO100
does not have a partial deletion of the IS1016–
bexA gene.
DISCUSSION
The number of invasive infections caused by
H. influenzae serotypes other than serotype b has
increased, and there is increasing concern that
non-b serotypes will become more virulent, or
that the already more virulent non-b serotypes
will become more prevalent [1,2,23,24]. In part,
this is a consequence of the success of the Hib
vaccine, which, ironically, may have created an
ecological niche for the other H. influenzae sero-
types. The genetic structure of the two H. influ-
enzae isolates described in this study provides an
important insight into the mechanism for the
occurrence of non-serotype b systemic H. influen-
zae disease. As reported here and elsewhere
[7,23,24], the genetic structure of virulent serotype
a strains mirrors the genetic structure of virulent
serotype b strains with respect to the duplication
of the cap gene and, in some instances, partial
deletion of the bexA gene locus. Previous studies
showed that Hib strains with five copies of the cap









Fig. 2. Southern hybridisation analysis of SmaI or ApaI
digests with a 1.1-kb probe for serotype a-specific genes.
(a) Chromosomal DNA digested with SmaI or ApaI and
separated by field inversion gel electrophoresis. (b) South-
ern blot of chromosomal DNA from KO100 and KO101
hybridised to the 1.1-kb type a-specific probe. M, lambda
ladder molecular size marker.
(a)
(b)Production of PCR products using various primer sets
Strain no. (source)

























Primer set, see Table 1.+/- indicates if a PCR product of the size indicated
was produced or not produced using the indicated primer set.   
Fig. 3. Schematic diagram of the cap locus in KO100 and
KO101. (a) The KO100 locus consists of directly repeated
duplication of cap genes, with each set containing three
DNA segments flanked by copies of IS1016, region I,
region II and region III, as indicated. KO101 has one copy
of IS1016. (b) Primer sets A, B, C, D, E, F, G and H were
used to generate the amplification products indicated. CSF,
cerebrospinal fluid.




KO100 (CSF) KO101 (blood)
fmol ⁄L Ratio fmol/L Ratio
rpoB 1655 1 1535 1
cap 3450 2.1 0 0
IS1016 4745 2.9 1735 1.1
Ratio is the fmol ⁄L of cap or IS1016 to the fmol ⁄L of rpoB, a single-copy gene.
CSF, cerebrospinal fluid.
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itol-phosphate than Hib strains that contained
two copies [25]. In addition, Hib strains with four
copies were significantly more resistant to com-
plement-mediated bacteriolysis and complement
opsonisation than were strains with two copies
[26]. These phenotypes may be stabilised by a
partial deletion of the bexA gene, partly because
more capsular material is produced and exported
to the cell surface [12,23,25]. Furthermore, and
somewhat paradoxically, it appears that there is
an advantage conferred on strains of H. influenzae
that readily lose the cap genotype [10,12]. It has
been speculated that the non-encapsulated form
has a selective advantage in normally colonised
body sites (e.g., the nasopharynx), as opposed to
the selective advantage of encapsulated strains in
normally sterile body sites [17]. Indeed, there is
evidence in serotype b strains that loss of the
capsule leads to an increased ability to adhere to
and invade human epithelial cells [27].
Interestingly, the potential for horizontal trans-
fer of the cap genes probably ensures that the
capacity to form a capsule is retained within a
population of bacteria [28,29]. The isolation in the
present study of a cap-negative variant from
blood, at the same time as a cap-positive strain
from CSF, requires further investigation. The
presence of a cap-negative organism in blood
was surprising because of the importance of the
polysaccharide capsule in resisting phagocytosis.
However, loss of the capsule may have provided
protection to the organism from antibodies
induced by this immunogen. The CSF isolate
would not be under the same antibody-driven
selective pressure as the blood isolate, explaining
why the CSF isolate retained the cap locus. The
cap-positive strain did not have the potentially
stabilising partial deletion of the bexA gene, and
was thus more likely to lose the cap-positive
genotype. The question as to whether the dynam-
ics of the conversion of cap-positive and
cap-negative strains influence virulence requires
further investigation.
The demonstration of a novel use for real-time
quantitative PCR in the detection and quantifi-
cation of cap genes has important clinical impli-
cations. The assay could be used to monitor
changes in the prevalence of virulent serotype a
strains, and a simple adaptation of the assay
would allow the detection and quantification of
cap genes in other H. influenzae serotypes.
Indeed, the assay has already been modified
successfully for the detection and quantification
of cap genes in serotype b strains (personal
unpublished data). It was concluded that KO100
does not have a partial deletion of the IS1016–
bexA gene, since the ratio of quantitative PCR
products for rpoB, cap and IS1016, respectively,
was 1:2:3. However, a ratio of 1:2:2 would
indicate a partial deletion, because the target
for primer set M (Table 2) is within the 1.2-kb
portion of the bexA and IS1016 region that is
deleted. Thus, it is possible to adapt the assay to
detect a partial deletion of the bexA gene, thereby
allowing a relatively simple and rapid method
for monitoring two of the predominant genetic
factors involved in H. influenzae virulence.
Clearly, further studies are required to charac-
terise the impact of cap gene loss on pathogenicity
and virulence of H. influenzae type a. In particular,
it would be of interest to determine the effect of
cap gene loss on uptake and survival in phago-
cytes, e.g., granulocytes and macrophages.
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